InvestorsHub Logo
Followers 30
Posts 5054
Boards Moderated 0
Alias Born 01/07/2020

Re: anfla post# 291262

Friday, 08/14/2020 11:17:39 AM

Friday, August 14, 2020 11:17:39 AM

Post# of 425939
anfla@ Se your points - and you might be right.

But what happens in 2029 - when we know Teva is in the market of generics.

I dont necessarily se artificial EPA as a competitor. More like a supplement (pipeline product) as you say in a number of years - when Vascepa is nearing the patent runout date 'for sure' in US.

Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News